Earlier this week the Second Circuit affirmed a lower court’s holding which found that drug manufacturer Pfizer Inc.’s practice of providing copay assistance to Medicare beneficiaries violated the Federal Anti-Kickback Statute (“AKS”).... Read More
The Department of Justice (DOJ)’s enforcement efforts aimed at speaker programs have not slowed since the DOJ filed criminal and civil actions against Insys, its executives, and scores of physicians relating to the off-label promotion of Subsys,... Read More
On June 29, 2022, the Department of Justice (“DOJ”) announced the formation of the New England Prescription Opioid (NEPO) Strike Force. This strike force will investigate and vigorously prosecute healthcare providers involved in healthcare fraud... Read More
According to the DOJ’s indictment, Ms. Lavache prescribed DME for Medicare beneficiaries without conducting any consultations with the said beneficiaries. As a result, she allegedly caused the submission of false claims to Medicare totaling... Read More
Frier Levitt is pleased to announce the dismissal of a State Licensing Board’s complaint against one of its clients, an experienced maxillofacial surgeon who currently owns and operates a number of successful medical practices across the United... Read More
Frier Levitt is pleased to announce the successful resolution of a federal investigation by the United States Attorney’s Office for the District of Maryland and the Drug Enforcement Administration (DEA) regarding alleged violations of the... Read More
The government increasingly has its sights set on various healthcare frauds that result in major financial losses to its healthcare programs such as Medicare, Medicaid, and TRICARE. Recently, the expanded enforcement efforts have included the foot... Read More
In its ongoing effort to combat healthcare fraud, the Department of Justice (“DOJ”) arrested and charged a New York orthopedic surgeon for allegedly submitting approximately $10 million in fraudulent claims to Medicare on April 21, 2022. These... Read More
On April 20, 2022, the Department of Justice (DOJ) announced criminal charges against twenty-one (21) defendants in nine federal courts across the country for their roles in Coronavirus-related healthcare fraud schemes that resulted in more than... Read More
The healthcare industry in general, and compounding pharmacies in particular, have, over the last several years, faced increased government scrutiny into their business practices, which has corresponded with unrelenting enforcement actions. Though... Read More
